BMRN vs ECL
Biomarin Pharmaceutical Inc (BMRN) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the BMRN and ECL stock pages for the full models.
Not investment advice.